OTCMKTS:AVCTF Avacta Group (AVCTF) Stock Price, News & Analysis $0.94 0.00 (0.00%) As of 10/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Avacta Group Stock (OTCMKTS:AVCTF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Avacta Group alerts:Sign Up Key Stats Today's Range$0.94▼$0.9450-Day Range$0.90▼$1.0552-Week Range$0.74▼$1.23VolumeN/AAverage Volume23,010 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Avacta Group plc is a United Kingdom-based life sciences company focused on developing targeted cancer treatments. Its principal technology platform, pre|CISION, is designed to activate medicines selectively within the tumor microenvironment, with the goal of improving treatment effectiveness while reducing exposure to healthy tissue. The company’s lead clinical program is AVA6000, a tumor-activated form of doxorubicin being investigated for the treatment of solid tumors, including soft-tissue sarcoma. Avacta is also developing additional pre|CISION-based therapeutic candidates and has used its Affimer biologics platform to support the discovery and development of engineered binding proteins for therapeutic applications. Avacta was established in 2003 and has historically operated across therapeutics and diagnostics, including collaborations and services for pharmaceutical, biotechnology and diagnostic companies. The group is headquartered in the United Kingdom and works with international commercial and research partners. Its shares trade on the London Stock Exchange, with the company also represented in the U.S. over-the-counter market under the symbol AVCTF.AI Generated. May Contain Errors. Read More Receive AVCTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avacta Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AVCTF Stock News HeadlinesAvacta Group Plc Reports Earnings Results for the Half Year Ended June 30, 2026September 30, 2026 | marketscreener.comMAvacta H1 Loss Widens As AVA6103 Advances Toward 2027 DataSeptember 30, 2026 | rttnews.comA new type of AI could unleash gains of up to 10,000%A new AI category called Accelerated AI is starting to gain traction, and most investors haven't caught on yet. Early movers in past technology shifts have seen outsized results, and this emerging niche is drawing comparisons. Get the name and ticker of the leading Accelerated AI company making waves right now.October 4 at 1:00 AM | Brownstone Research (Ad)Avacta sospende le negoziazioni per avviare un aumento di capitaleSeptember 30, 2026 | it.investing.comAvacta Group plc: Interim Results for the Six Months to June 30, 2026, and Business UpdateSeptember 30, 2026 | markets.businessinsider.comLa piattaforma pre|CISION di Avacta vince un premio R&S nel settore farmaceutico UKSeptember 25, 2026 | it.investing.comAvacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic CancerSeptember 25, 2026 | finance.yahoo.comAvacta Appoints Mats Blom to the Board of Directors as Chair of Audit CommitteeSeptember 14, 2026 | markets.businessinsider.comSee More Headlines AVCTF Stock Analysis - Frequently Asked Questions How have AVCTF shares performed this year? Avacta Group's stock was trading at $0.7780 at the beginning of the year. Since then, AVCTF stock has increased by 20.5% and is now trading at $0.9376. How do I buy shares of Avacta Group? Shares of AVCTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/04/2026Next Earnings (Estimated)10/05/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:AVCTF CIKN/A Webwww.avacta.com Phone44.1904.21.7070FaxN/AEmployees120Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (OTCMKTS:AVCTF) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredFree Stock: Economist calls it “the world’s most important machine.”Nvidia's most expensive chip component isn't made by Nvidia. Jeff Brown, former semiconductor executive, says ...Brownstone Research | SponsoredThe case for $20,000 gold before year endPresident Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and A...Stansberry Research | SponsoredA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avacta Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
